RBC Capital Keeps Their Buy Rating on R1 RCM (RCM)
TowerBrook, CD&R in Advanced Talks to Make Offer for Health IT Firm R1 RCM
Market Chatter: R1 RCM to Receive Joint Bid From TowerBrook, CD&R
R1 RCM (RCM) might receive a competing takeover offer from TowerBrook Capital Partners and Clayton, Dubilier & Rice, in addition to a $13.25-per-share bid from New Mountain Capital, Bloomberg
Express News | Tcp-Asc Achi Series Lllp Says on July 8, Partnership Was Advised That R1 RCM, Had Approved Standstill Waiver Request
Express News | Tcp-Asc Achi Series Lllp: Currently in Advanced Discussions to Finalize Proposal at Price Level Above Coyco Proposal to R1 RCM Inc - SEC Filing
Express News | Tcp-Asc Achi Series Lllp Says Partnership Has Aligned With Clayton, Dubilier & Rice to Make Joint Proposal for R1 RCM
R1 RCM Focus of Rival Takeover Bid by TowerBrook, CD&R - Report
S&P 500 Futures Rise In Premarket Trading; CrowdStrike Holdings, Autoliv Lag
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, SentinelOne Inc. (S) was up 5.6% in pre-market
Express News | R1 RCM to Release Second Quarter 2024 Results on August 7, 2024
Unusual Options Activity: XOM, SBUX and Others Attract Market Bets, XOM V/OI Ratio Reaches 100.0
EST Jul 11th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Evercore Maintains R1 RCM(RCM.US) With Hold Rating, Maintains Target Price $14
Evercore analyst Elizabeth Anderson CFA maintains $R1 RCM(RCM.US)$ with a hold rating, and maintains the target price at $14.According to TipRanks data, the analyst has a success rate of 38.9% and a
TD Cowen Maintains R1 RCM(RCM.US) With Buy Rating, Maintains Target Price $20
TD Cowen analyst Charles Rhyee maintains $R1 RCM(RCM.US)$ with a buy rating, and maintains the target price at $20.According to TipRanks data, the analyst has a success rate of 46.7% and a total
Analysts' Opinions Are Mixed on These Healthcare Stocks: R1 RCM (RCM) and AbbVie (ABBV)
R1 RCM Is Maintained at Hold by Deutsche Bank
R1 RCM Is Maintained at Hold by Deutsche
R1 RCM Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/09/2024 24.37% Deutsche Bank $14 → $16 Maintains Hold 07/08/2024 32.14% Morgan Stanley $17 → $17
Deutsche Numis Maintains R1 RCM(RCM.US) With Hold Rating, Raises Target Price to $16
Deutsche Numis analyst George Hill maintains $R1 RCM(RCM.US)$ with a hold rating, and adjusts the target price from $14 to $16.According to TipRanks data, the analyst has a success rate of 53.4% and
Express News | R1 RCM Inc : Deutsche Bank Raises Target Price to $16 From $14
Top Gap Ups and Downs on Monday: NOW, INTC, EQNR and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Express News | R1 RCM Shares Are Trading Higher After Morgan Stanley Maintained an Overweight Rating and a $17 Price Target. The Stock Fell Last Week After the Company Announced New Mountain Capital Is No Longer Interested in Pursuing a Joint Proposal With TCP-ASC
Stocks Hold Steady, Small Caps Rise, French Equities Slip After Surprise Win By Left-Wing Bloc: What's Driving Markets Monday?
U.S. stocks started the week on a neutral note, with the S&P 500 and Nasdaq 100 indices hovering around the flatline by midday trading in New York. This comes after both indices reached fresh record h